S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

RayzeBio (RYZB) Short Interest Ratio & Short Volume

Notice: This company has been marked as potentially delisted and may not be actively trading.

RayzeBio Short Interest Data

Current Short Volume
722,400 shares
Previous Short Volume
821,600 shares
Change Vs. Previous Month
-12.07%
Dollar Volume Sold Short
$44.86 million
Short Interest Ratio / Days to Cover
1.0
Last Record Date
January 31, 2024
Outstanding Shares
59,920,000 shares
Float Size
31,080,000 shares
Short Percent of Float
2.32%
Today's Trading Volume
0 shares
Average Trading Volume
553,592 shares
Today's Volume Vs. Average
0%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling RayzeBio ?

Sign up to receive the latest short interest report for RayzeBio and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RYZB Short Interest Over Time

RYZB Days to Cover Over Time

RYZB Percentage of Float Shorted Over Time

RayzeBio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2024722,400 shares $44.86 million No Change2.3%1 $62.10

RYZB Short Interest - Frequently Asked Questions

What is RayzeBio's current short interest?

Short interest is the volume of RayzeBio shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 722,400 shares of RYZB short. 2.32% of RayzeBio's shares are currently sold short. Learn More on RayzeBio's current short interest.

What is a good short interest ratio for RayzeBio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RYZB shares currently have a short interest ratio of 1.0. Learn More on RayzeBio's short interest ratio.

Which institutional investors are shorting RayzeBio?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of RayzeBio: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for RayzeBio?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.32% of RayzeBio's floating shares are currently sold short.

Is RayzeBio's short interest increasing or decreasing?

RayzeBio saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 722,400 shares, a decrease of 12.1% from the previous total of 821,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is RayzeBio's float size?

RayzeBio currently has issued a total of 59,920,000 shares. Some of RayzeBio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. RayzeBio currently has a public float of 31,080,000 shares.

How does RayzeBio's short interest compare to its competitors?

2.32% of RayzeBio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to RayzeBio: Fortrea Holdings Inc. (5.21%), Xenon Pharmaceuticals Inc. (3.66%), Arcellx, Inc. (9.85%), MoonLake Immunotherapeutics (16.21%), Summit Therapeutics Inc. (26.25%), MorphoSys AG (1.08%), Merus (5.86%), Krystal Biotech, Inc. (7.61%), NewAmsterdam Pharma (0.86%), Ardelyx, Inc. (15.05%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short RayzeBio stock?

Short selling RYZB is an investing strategy that aims to generate trading profit from RayzeBio as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against RayzeBio?

A short squeeze for RayzeBio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RYZB, which in turn drives the price of the stock up even further.

How often is RayzeBio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RYZB, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:RYZB) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners